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ABSTRACT
This study was conducted to investigate how germinated brown rice (GBR) extracts stimulate human mononuclear cell (MNC) growth,
secretion of cytokines (IL-1β, IFN-γ and TNF-α) and nitric oxide, and subsequently inhibit the growth of U937 cells. The results indicate
that through the use of phosphate buffer solution (PGBR), alkali (AGBR) and ethanol (EGBR), the extracts had a significant inhibitory
effect on U937 cell growth. Ultimately, the extracts produced an inhibition rate of over 50%. As the concentration was increased up to
1,000 μg/mL, the U937 cell growth inhibition for the three extracts surpassed 60%. The cytokines (IL-1β, TNF-α and IFN-γ) expression of
PGBR-MNC-CMs (conditioned mediums) for 3 days (at 1000 μg/mL) was 1798, 2347 and 1462 pg/mL, respectively. The EGBR showed
significant stimulation on the growth of MNC. The results of this study can be used as references for the development of GBR health foods.
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INTRODUCTION
Rice (Oryza sativa L.) is not only the foremost food
crop of the world but also one of the cheapest sources of food
energy and proteins. Rice is a staple food for more than half
the world’s population. Recent evidence indicates that many
bioactive compounds do not uniformly exist in a cereal grain
but are concentrated in the husk and bran layers(1,2). It has
been reported that several ingredients isolated and derived
from rice possess various pharmacological and biological
activities. Ghoneum & Abedi(3) found that modified arabinoxylan rice bran enhanced the activity of peritoneal natural
killer cells in aged C57BL/6 and C3H mice; Fan et al.(4)
found the lipoprotein fraction of rice bran was capable of
inducing apoptosis in human endometrial adenocarcinoma
cells; Liau et al.(5) reported that rice could inhibit growth and
induce differentiation of human leukemic U937 cells through
activation of peripheral blood mononuclear cells (MNCs); Li
et al.(6) found that the extracts of brown rice and rice bran
could inhibit the growth of human colon cancer cells.
When the germination of cereals and legume seeds,
including rice(7,8), barley(9), and oat(10), is activated, proteins,
starch and non-starch polysaccharides are decomposed,
leading to an increase in oligosaccharides and amino acids.
A vast amount of literature has reported on brown rice,
* Author for correspondence. Tel: +886-4-8511888 ext. 2283;
Fax: +886-4-851-1322; E-mail: feccy@mail.dyu.edu.tw

pre-germinated brown rice (pre-GBR) and GBR for nutrition
and as a functional food(8,11-13). Previous literature, however,
is limited in regard to brown rice, pre-GBR and GBR in their
use for treating cancer cells and for their immunomodulatory
activities. Cytokines are recognized as one of the most versatile players in the immune system(14-16). They are involved in
the pathogenesis and control of infectious diseases, tumors,
autoimmune processes and chronic degenerative diseases. In
this study, the bioactive compounds of GBR, such as oligosaccharides, lipoproteins, and amino acids, were extracted
sequentially by phosphate buffer, alkali, and ethanol solutions, and the relationship between the extracts and the
growth of human leukemic U937 cells was investigated. This
study also attempted to use the extracts to activate MNCs to
induce leukemic U937 cell differentiation and inhibit the cell
growth through cytokine secretion.

MATERIALS AND METHODS
I. Rice Sample
The GBR sample, germinated by Oryza sativa L.
Japonica Taken 9 and free of mycotoxin and heavy metal
contamination, was purchased from Asiarice Biotech. Inc.
(Taipei, Taiwan).
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II. Reagents
Roswell Park Memorial Institute-1640 (RPMI) and fetal
bovine serum (FBS) were purchased from Hyclone (Logan,
UT, USA). Sodium bicarbonate, HEPES, L-glutamine and
sodium pyruvate were purchased from Sigma Chemical
Co. (St. Louis, MO, USA). Trypan blue was obtained from
e-Bioscience (CA, USA).
III. Preparation of Phosphate, Alkali and Ethanol Extracts
of GBR
In order to obtain the bioactive compounds in GBR,
such as oligosaccharides, lipoproteins and amino acids, the
GBR sample was extracted sequentially by phosphate buffer,
alkali, and ethanol solutions, which was modified from the
methods of Nagai and Inoue(17) and Guo et al.(18). Three
grams of GBR powder were suspended and extracted with
30 volumes of 10 mM of sodium phosphate buffer (pH 7.0)
and shaken at 4°C for 24 h. The extracts were centrifuged
at 2817 ×g for 30 min and the supernatants were pooled,
dialyzed against distilled water, lyophilized and denoted as
PGBR. The residue was extracted with 30 mL of 0.1 N of
NaOH at 4°C for 24 h. The extracts were also centrifuged at
2817 ×g for 30 min. The supernatants were pooled, adjusted
to pH 7.0 with diluted HCl, dialyzed against distilled water,
lyophilized and denoted as AGBR. The residue after alkali
extraction was further extracted with 30 mL of 75% ethanol at
4°C for 24 h. The extracts were centrifuged at 2817 ×g for 30
min. The supernatants were pooled, dialyzed against distilled
water, lyophilized and denoted as EGBR. All the samples
were stored in a desiccator at -80°C until use.
IV. Preparation of Mononuclear Cells-Conditioned Medium
(MNC-CM)
Human peripheral blood was obtained from healthy
adult volunteers between the ages of 22 and 25. Mononuclear
cells were recovered by adding the blood to Ficoll-Hypaque
solution (1.077 g/mL; Sigma Chemical Co., USA) and centrifuging at 400 × g for 30 min. A suspension of 1.0 × 107 cells/
mL in a RPMI 1640 medium was prepared. GBR powder was
dissolved in phosphate buffer solution (8 g of NaCl, 1.15 g
of Na2HPO4, 0.2 g of KH2PO4, 0.2 g of KCl dissolved in 1
L ddH2O; pH 7.0), and added to the above-mentioned cell
suspension in an amount between 100 and 1,000 μg solids/
mL medium. The medium containing both cells and the
extract of GBR was placed in a humidified 5% CO2 atmosphere incubator at 37°C for 24 and 72 h, respectively. Then,
the medium was filtered through a 0.22-μm membrane and
the cell-free filtrate was collected as the extracts of GBRstimulated human peripheral blood GBR-MNC-CM. It was
then stored at -80°C until use.
V. Cell Cultures
U937 cell lines were obtained from the Bioresource

Collection and Research Center (BCRC). The cells were
cultured in RPMI 1640, supplemented with 10% heatinactivated fetal bovine serum, penicillin (100 units/mL),
streptomycin (100 μg/mL), HEPES (100 μg/mL), sodium
pyruvate and sodium bicarbonate. The cells were subsequently incubated at 37°C in a humidified atmosphere
containing 5% CO2.
VI. GBR Extract Affecting Cell Death as Determined by
Trypan Blue
U937 cells at 1 × 105 cells/mL treated with GBR-MNCCM at 100, 200, 500, 800 and 1000 μg/mL were placed into
a 12-well microtiter plate for 5 days at 37°C in 5% CO2
(cell/sample ratio = 4/1, v/v). The number of dead cells was
counted using a trypan blue dye exclusion test(19). The experiment was conducted in triplicate and growth inhibition (%)
was calculated by applying the following equation:
Growth inhibition (%) = [1 – (Number of live cells after
incubation for 5 days / total cells before incubation)] × 100 %
VII. Evaluation for Cytokine Production in GBR-MNC-CM
Mononuclear cells were stimulated with different GBR
extracts at various concentrations for 72 h. The cell suspension was filtrated to obtain GBR-MNC-CM. The contents
of cytokines IL-1β, IFN- and TNF-α were determined using
commercial enzyme-linked immunoassay (ELISA) kits
(Bender, USA).
VIII. Measurement of Nitric Oxide Production as an Assay
of NO Release
The NO production by GBR-MNC-CM was determined
by assaying the Griess reaction(20). After an incubation of 3
days, 100 μL of the MNC-CMs were mixed with an equal
volume of Griess reaction (1% sulfanilamide/ 0.1% NED/
2.5% H3PO4) in a 96-well flat-bottomed microtiter plate and
incubated at room temperature for 15 min. The absorbance
was read at 540 nm by a microplate reader (μQuant, from
BIO-TEK Instruments, INC., USA). The nitrite concentration was determined by comparison with a sodium nitrite
standard curve.
IX. Growth of MNCs as Determined by MTT Assay
The MTT assay for determining the growth of MNCs
was modified from those of Liao et al.(5) and Ma et al.(21).
Human mononuclear cells were incubated with various
concentrations of GBR extracts, medium, phosphate buffer
saline (PBS, control) and phytohemagglutinin (PHA, positive control, 5 μg/mL) at 37°C in 5% CO2 for 1 and 3 days
(cell/sample ratio = 4/1, v/v). Then, 25 μL of MTT reagent
was added and the cells incubated for another 4 h at 37°C in
5% CO2. One hundred microliters of MTT lysis buffer (25
mL of N, N-dimethyl formamide and sodium dodecyl sulfate
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10 g/mL were mixed) was added and the cells were incubated for 16 - 18 h at 37°C in 5% CO2. The absorbance was
measured at 570 nm.
The growth index was calculated by applying the
following equation:
Growth index = (MTT value of sample stimulated cells
/ MTT value of medium control cells)
X. Statistical Analysis
In this study, each experiment was conducted in triplicate
and the results were analyzed through a one-way analysis of
variance using the SAS (Statistic Analytic System)(22).

RESULTS AND DISCUSSION

concentrations changes irregularly but increases apparently
by increasing sample concentrations, which is dose-dependent. The result reveals that the components in the extracts
can inhibit the growth of U937 cells. However further study
on the compositions of the extracts is needed.
Many researches on the inhibition of U937 cell growth
have been reported. The growth inhibition of U937 cells
treated with MNC-CM prepared with the cold water extract
of Flammulina velutipes at 800 μg/mL was 60%(16). The
water extract from rice (Oryza sativa L.) at 500 μg/mL was
35%(5). The bovine skimmed colostrums collected on the
second postpartum day at 800 μg/mL was 50%(21), and the
semi-purified polysaccharides of Antrodia camphorate at 100
μg/mL came in at 55%(23). Comparing with the researches
mentioned above suggests that the extracts of GBR exhibit an
inhibitory effect on the growth of U937 cells.
II. Cytokine Content in GBR-MNC-CMs

I. Inhibition of U937 Cell Growth by GBR-MNC-CM
The experimental results illustrating the effects of GBR
extract on the growth of U937 cells are shown in Table 1.
MNC-CMs prepared with various GBR extracts are more
effective on the inhibition of U937 cells than the PBS-treated
control group and PHA-treated group. Growth inhibition
of the U937 cells treated with PGBR-, AGBR- and EGBRMNC-CM (500 μg/mL) for 72 h are 53.55, 59.20 and 44.13%,
respectively. For the sample concentration at 1000 μg/mL
for 72 h, the growth inhibition ratio of U937 cells is over
60%. Inspection of the results presented in Table 1 shows that
the inhibition on U937 cell growth at different samples and

To investigate the effect of GBR extracts on cytokinestimulating activity, human mononuclear cells (MNC)
were treated with various GBR extracts at 1000 μg/mL.
The contents of cytokines (IL-1β, TNF-α and IFN-γ) in
the supernatants of the cultures were then determined. The
IL-1β contents in PGBR-, AGBR- and EGBR-MNC-CM
at 1000 μg/mL in a 72 h period were 1798, 1862 and 2614
pg/mL, respectively (Figure 1); the TNF-α contents were
2347, 915 and 1881 pg/mL, respectively (Figure 2); and the
IFN-γ contents were 1461, 1135 and 908 pg/mL, respectively
(Figure 3). As shown in Figures 1, 2 and 3, the samples had
higher levels in IL-1β, TNF-α and IFN-γ than the medium

Table 1. Growth inhibition of U937 cells treated with various extracts of germinated brown rice for 24 and 72 h
Growth inhibition (%)
24 h
Samples

Concentration (μg/mL)
100

200
a

500
a

800
a

1000
b

48.35 ± 1.32

52.14 ± 3.63

49.83 ± 6.11

33.51 ± 2.09b

45.61 ± 1.80a

49.49 ± 1.19a

57.39 ± 2.22a

c

a

b

a

PGBR

40.25 ± 3.26

AGBR
EGBR

26.03 ± 3.04

48.08 ± 1.12

Medium

41.88 ± 5.73

51.23 ± 2.68

59.23 ± 4.00a
50.63 ± 2.89ab
53.10 ± 1.49a

7.83 ± 0.90

PBS

14.17 ± 1.52

PHA (5 μg/mL)

11.23 ± 1.44
Growth inhibition (%)

72 h
Samples
PGBR

Concentration (μg/mL)
100
41.80 ± 6.31

200
a

38.01 ± 1.74

a

800
a

53.55 ± 3.04

a

1000
a

62.95 ± 1.80a

a

58.51 ± 4.46

AGBR

33.86 ± 2.98

39.72 ± 1.80

59.20 ± 3.27

62.23 ± 4.24

65.37 ± 3.99a

EGBR

41.88 ± 1.08a

41.55 ± 3.45a

44.13 ± 2.49b

60.77 ± 2.95a

65.65 ± 3.15a

Medium

b

500
a

9.63 ± 0.69

PBS

15.58 ± 0.85

PHA (5 μg/mL)

21.64 ± 1.41

a-c: Data bearing identical letters in the same column are not significantly different (p > 0.05).
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Figure 3. Changes in IFN-γ contents of MNC-conditioned mediums
prepared with various concentrations of germinated brown rice extracts
for 72 h. Results were obtained from three separate experiments.
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Figure 1. Changes in IL-1β contents of MNC-conditioned mediums
prepared with various concentrations of germinated brown rice extracts
for 72 h. Results were obtained from three separate experiments.
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Figure 2. Changes in TNF-α contents of MNC-conditioned mediums
prepared with various concentrations of germinated brown rice extracts
for 72 h. Results were obtained from three separate experiments.

Figure 4. Changes in nitric oxide contents of MNC-conditioned
mediums prepared with various concentrations of germinated brown rice
extracts for 72 h. Results were obtained from three separate experiments.

control and the PBS groups. From the results, it concludes
that the GBR extracts are able to stimulate MNCs to secrete
cytokines.

EGBR-MNC-CMs at 500, 800 and 1000 μg/mL for 72 h were
higher than those of AGBR-MNC-CMs, the medium control
and the PBS groups. Nitric oxide could induce the death of
U937 cells(24). It may be stated from the above results that
PGBR and EGBR extracts can enhance the NO secretion of
MNCs and inhibit the growth of U937 cells.

III. Effect on Nitric Oxide Production of MNC
Nitric oxide (NO) is recognized as one of the most
versatile players in the immune system. It is involved in
the pathogenesis and control of infectious diseases, tumors,
autoimmune processes and chronic degenerative diseases(14).
Yang and Park(24) reported that antioxidant enzyme inhibitors could enhance nitric oxide-induced death of U937 cells.
As shown in Figure 4, the NO content of PGBR-MNC-CMs
at 100 μg/mL for 72 h was 0.80 μM which was higher than
those of AGBR-MNC-CMs (0.68 μM) and EGBR-MNCCMs (0.62 μM). The NO contents of PGBR-MNC-CMs and

IV. Effect on the Growth of MNC
The results shown in Figure 5 illustrated the effect of
GBR extracts on MNC growth. The greatest growth index
of up to 1.12 ± 0.20 was achieved through a treatment of
EGBR at 100 μg/mL for 72 h. PGBR-MNC-CM demonstrated the inhibition for MNC growth at 100 - 800 μg/mL.
AGBR-MNC-CM did not significantly affect MNC growth.
The results reveal that EGBR is able to stimulate the MNC
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Figure 5. The growth index of human MNCs after incubation with
various concentrations of germinated brown rice extracts for 72 h.
Results were obtained from three separate experiments.

growth. On the other hand, different GBR extracts give a
further account of stimulation of MNC growth and/or inhibition. It seems that different methods of extraction can
account for different bioactivities to affect the growth and/or
inhibition of MNCs.

CONCLUSIONS
In this study, germinated brown rice extract was shown to
significantly inhibit the growth of human leukemic U937 cells
and exhibit immunomodulatory activity. The results showed
that GBR extract exhibits immunomodulatory effect through
the modulation of MNC growth and secretion of cytokines
(IL-1β, TNF-α and IFN-γ) as well as NO production from
MNC into MNC-CM. Drawing from the results obtained in
this study, we also propose the possibility that GBR extracts
may be used to bolster human health. Further studies will
focus on the mechanism that induces cytokine secretion in
MNC and confirm the composition of GBR extracts.
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